Polartechnics moves into Pakistan
Monday, 09 March, 2009
Sydney’s Polartechnics has received another international order for its TruScreen cervical cancer screening technology, this time with Pakistan.
The Pakistani Government has initially ordered 100 units but expects to order more in the future.
TruScreen is a point of care detection device for cervical cancer. Cervical cancer is the fourth most common cancer in Pakistan, which has a female population of more than 85 million.
Last month, Polartechnics signed distribution agreements with major medical companies in Indonesia, Thailand, the Philippines and Sri Lanka.
Polartechnics also produces a self-administered HPV test called CerviScreen under a joint venture with Genera BioSystems and Gribbles Pathology.
Reproductive impacts of PFAS exposure revealed
New studies have found that PFAS exposure can significantly alter male reproductive health, and...
'Longevity gene' could reverse damage from rapid aging disease
A gene found in supercentenarians, who live exceptionally long lives, could counteract the...
How a common gene mutation increases liver disease risk
Liver damage can be caused in people after exposure to high levels of acrolein, especially in...
